ABCL
Price
$4.49
Change
+$0.20 (+4.66%)
Updated
Mar 27, 6:59 PM EST
41 days until earnings call
ABEO
Price
$7.34
Change
-$0.02 (-0.27%)
Updated
Mar 27, 6:59 PM EST
43 days until earnings call
Ad is loading...

Analysis and predictions ABCL vs ABEO

Header iconABCL vs ABEO Comparison
Open Charts ABCL vs ABEOBanner chart's image
AbCellera Biologics
Price$4.49
Change+$0.20 (+4.66%)
Volume$742.3K
CapitalizationN/A
Abeona Therapeutics
Price$7.34
Change-$0.02 (-0.27%)
Volume$73.9K
CapitalizationN/A
View a ticker or compare two or three
ABCL vs ABEO Comparison Chart

Loading...

ABCLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ABEODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABCL vs. ABEO commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ABEO is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ABCL: $4.50 vs. ABEO: $7.33)
Brand notoriety: ABCL and ABEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 88% vs. ABEO: 33%
Market capitalization -- ABCL: $1.32B vs. ABEO: $200.51M
ABCL [@Biotechnology] is valued at $1.32B. ABEO’s [@Biotechnology] market capitalization is $200.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileABEO’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ABEO’s FA Score: 0 green, 5 red.
According to our system of comparison, ABEO is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while ABEO’s TA Score has 2 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • ABEO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than ABEO.

Price Growth

ABCL (@Biotechnology) experienced а -4.86% price change this week, while ABEO (@Biotechnology) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.41%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ABCL is expected to report earnings on May 08, 2024.

ABEO is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (+4.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ABCL with price predictions.
OPEN
A.I.dvisor published
a Summary for ABEO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ABCL($1.32B) has a higher market cap than ABEO($201M). ABCL has higher P/E ratio than ABEO: ABCL (11.98) vs ABEO (0.11). ABEO YTD gains are higher at: 46.307 vs. ABCL (-21.191). ABEO has higher annual earnings (EBITDA): -50.57M vs. ABCL (-192.16M). ABCL has more cash in the bank: 761M vs. ABEO (52.2M). ABEO has less debt than ABCL: ABEO (5.4M) vs ABCL (77.4M). ABCL has higher revenues than ABEO: ABCL (38M) vs ABEO (3.5M).
ABCLABEOABCL / ABEO
Capitalization1.32B201M656%
EBITDA-192.16M-50.57M380%
Gain YTD-21.19146.307-46%
P/E Ratio11.980.1110,624%
Revenue38M3.5M1,086%
Total Cash761M52.2M1,458%
Total Debt77.4M5.4M1,433%
FUNDAMENTALS RATINGS
ABEO: Fundamental Ratings
ABEO
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLABEO
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
ABCLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ABEODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABVKX17.710.27
+1.55%
AB Value K
OSMYX43.170.29
+0.68%
Invesco International Small-Mid Com Y
CADRX20.220.06
+0.30%
Columbia Large Cap Growth Opp Inst2
CPCCX3.36N/A
N/A
Comstock Capital Value C
MMYLX8.66N/A
N/A
MassMutual Small Company Val Adm

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with VCYT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+4.90%
VCYT - ABCL
56%
Loosely correlated
+2.65%
DNA - ABCL
54%
Loosely correlated
+2.80%
RXRX - ABCL
54%
Loosely correlated
-1.45%
NTLA - ABCL
54%
Loosely correlated
+2.82%
ADPT - ABCL
51%
Loosely correlated
+0.52%
More

ABEO and

Correlation & Price change

A.I.dvisor tells us that ABEO and AXON have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABEO and AXON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
-0.41%
AXON - ABEO
31%
Poorly correlated
-1.13%
XNCR - ABEO
29%
Poorly correlated
+4.18%
ABUS - ABEO
29%
Poorly correlated
+4.02%
AMRN - ABEO
28%
Poorly correlated
+2.68%
XENE - ABEO
28%
Poorly correlated
+0.71%
More